查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1304512

全球乳腺成像市场 - 2023-2030

Global Breast Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球乳腺成像市场规模在2022年达到42亿美元，预计到2030年将实现79亿美元的丰厚增长。预计在2023-2030年期间，全球乳腺成像市场将呈现8.4%的复合年增长率。技术的不断进步和对新型产品投资的不断增长推动了乳腺成像市场需求的发展趋势。

乳腺成像市场包括确定产品存在的方式和应用。尽管乳腺癌在女性中更为常见，但男性也可能罹患乳腺癌。超声波、核成像MRI、乳腺X线摄影和热成像是最常用于检测乳腺癌和相关疾病的乳腺成像程序。新模式的推出和癌症患者的增加是推动全球乳腺成像市场发展的主要因素。

乳腺成像的市场范围包括乳腺癌、乳腺疾病和其他应用，这增加了乳腺成像的市场份额。全球乳腺成像市场正在不断扩大，其原因包括不断增加的研究和开发，以及各国即将批准的新产品，这也为乳腺成像市场的增长创造了积极的前景。

市场动态

技术进步将推动乳腺成像市场的增长

乳腺X线照相术一直是放射科医生乳腺癌成像工具的重要组成部分。自问世以来，它大大降低了乳腺癌的死亡率，是及时发现乳腺癌的重要筛查和诊断工具。

乳腺X线照相术与技术同步发展，从胶片到数字乳腺X线照相术，再到数字乳腺断层合成术（DBT）。为了提高癌症检出率、减少假阳性和改善预后，每一次发展都不断解决放射医师面临的问题和患者的担忧。

对比增强乳腺X线摄影（CEM）可能是乳腺成像的下一个发展方向，也是这一演变的结果。尽管该技术诞生于近十年前，但最近才开始引起人们的注意，因为新出现的研究强调了它相对于传统辅助成像的优势。

为了帮助检测乳腺组织的异常，CEM使用与计算机断层扫描（CT）技术相同的造影剂。造影剂通过血管流经乳腺组织，在病变形成和增大的地方积聚，采用与CT和磁共振成像（MRI）类似的物理成像概念。

不断增加的研发和新型产品的推出为制造商创造了有利的机会

USPSTF建议年龄在50至74岁之间、有患乳腺癌平均风险的女性每两年进行一次乳房X光检查。40至49岁的女性应与医生或其他医生讨论何时开始以及多久进行一次乳房X光检查。

例如，2022年5月，Therapixel - 一家创建基于人工智能软件的女性健康组织 - 推出了MammoScreen 2D和3D，其最新版本可以使用以前的乳房X光照片进行分析。通过将其性能与先前的检测进行比较，MammoScreen变得更加有效。

设备的局限性将阻碍市场增长。

在每两年进行一次乳腺癌筛查的20年计划中，并非每种乳腺癌都能被发现。在每两年接受一次乳房X光检查的1000名妇女中，有77名妇女在20年内会罹患乳腺癌。其中21人将在乳房X光检查结果正常的情况下被诊断为癌症。

这种情况发生的条件是：所有乳腺癌患者都能存活；乳腺X光检查未发现癌症；乳腺X光检查时癌症尚未确定。据预测，在20年内每两年接受一次乳房X光检查的1000名妇女中，将有13人死于乳腺癌。乳房X光检查也是一种X射线检查。在X射线检查过程中会释放辐射，这一点与其他检查一样。

COVID-19影响分析

COVID-19疫情和全球封锁对各行各业的企业财务健康产生了影响。因此，美国食品和药物管理局(FDA)发布了COVID-19卫生紧急状态期间的指导方针，其中包括协助申办者和研究人员、确保试验参与者安全、遵循良好临床实践(GCP)以及降低试验完整性风险的一般注意事项。

俄乌战争影响分析

据估计，俄乌冲突对全球乳腺成像市场的影响较小，因为该地区的主要市场参与者较少。然而，原材料进出口的影响预计在预测期内对全球乳腺成像市场的增长影响不大。

目录

第一章 研究方法和范围

  • 研究方法
  • 研究目的和报告范围

第2章：定义和概述

第3章：执行摘要

  • 按模式分類的摘要
  • 按应用划分
  • 按终端用户划分
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 技术进步和新产品的不断推出
      • 乳腺癌发病率上升
    • 限制因素
      • 设备的局限性
    • 机会
      • 研发和新产品上市的增加
    • 影响分析

第五章：行业分析

  • 波特五力分析法
  • 供应链分析
  • 定价分析
  • 法规分析

第六章：COVID-19分析

  • COVID-19分析
    • COVID-19之前的情况
    • COVID-19期间的情景
    • COVID-19之后的情景
  • COVID-19期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第七章：按模式分类

  • X射线源
    • 乳腺摄影
    • 数字乳腺断层摄影
    • 对比增强数字乳腺X线摄影
  • 超声
    • 超声
    • 对比增强超声
    • 三维超声
    • 彩色/功率多普勒
    • 组织弹性成像
  • 磁场
    • 磁共振成像
    • 磁共振波谱成像
    • 弥散加权成像
  • γ射线
    • 正电子发射计算机断层扫描
    • 单光子发射计算机断层扫描
  • 非电离辐射
    • 光学成像
    • 乳腺微波成像

第八章：按应用分类

  • 乳腺癌
  • 乳腺疾病
  • 其他应用

第九章：按最终用户分类

  • 医院
  • 影像诊断中心
  • 专科诊所
  • 其他

第十章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 日本
    • 日本
      • 亚太其它地区
  • 中东和非洲
    • 主要地区动态

第十一章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • GE Healthcare
    • 公司概况
    • 产品组合和描述
    • 财务概况
    • 主要发展
  • Siemens Healthcare GmbH
  • FUJIFILM Corporation
  • Koninklijke Philips NV
  • Hologic, Inc.
  • Canon Medical Systems Corporation
  • General Medical Merate S.p.A.
  • Konica Minolta Healthcare Americas, Inc.
  • Metaltronica S.p.A
  • Planmed OY

第十三章 ：附录

简介目录
Product Code: MI878

Market Overview

The Global Breast Imaging Market reached US$ 4.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global breast imaging market is expected to exhibit a CAGR of 8.4% during the forecast period 2023-2030. The increasing technological advancements and the growing investments in novel products are driving up demand for breast imaging market trends.

The market for breast imaging includes modalities and applications that establish the existence of the products. Despite being more common in women, breast cancer can also affect men. Ultrasound, nuclear imaging MRI, mammography, and thermography are the breast imaging procedures most frequently used to detect breast cancer and associated diseases. The launch of new modalities and an increase in patients with cancer are the main factors propelling the global market for breast imaging.

The breast imaging market scope comprises application as breast cancer, breast diseases and others, which has increased the breast imaging market share. The global market for breast imaging is expanding as a result of factors including increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the breast imaging market growth.

Market Dynamics

Rising Technological Advancements will Drive the Growth of the Breast Imaging market

Mammography has existed as a crucial component of the radiologist's breast cancer imaging toolset. Since its creation, it has dramatically lowered the disease's mortality rates and is a crucial screening and diagnostic tool for the prompt identification of breast cancer.

Mammography has advanced alongside technology, going from film through digital mammography to digital breast tomosynthesis (DBT). To increase cancer detection rates, decrease false positives, and improve outcomes, each evolution has kept tackling the issues that radiologists face and the worries of patients.

Contrast-enhanced mammography (CEM), which may be the next development in breast imaging, is the result of this evolution. Although the technology was created almost 10 years ago, it has only lately begun to attract attention as a result of an emerging body of research that highlights its advantages over conventional supplementary imaging.

To help detect abnormalities in breast tissue, CEM uses the same contrast material as computed tomography (CT) technology. The contrast agent flows through the breast tissue via blood vessels and accumulates wherever lesions are forming and increasing, using similar physical imaging concepts as CT and magnetic resonance imaging (MRI).

Rising Research and Development and Novel Product Launches creates Lucrative Opportunities for Manufacturers

Women between the ages of 50 and 74 who have an average risk of developing breast cancer are advised by the USPSTF to undergo a mammogram once every two years. When to begin and how frequently to obtain a mammogram should be discussed with a doctor or another physician by women between the ages of 40 and 49.

For instance, in May 2022, Therapixel, an organization for women's health that creates AI-based software, unveiled MammoScreen 2D and 3D, its most recent version of which can use prior mammograms in analysis. By comparing its performance to earlier tests, MammoScreen becomes more effective.

Limitations Associated with Equipment Will Hamper the Growth of the Market.

Not every kind of breast cancer will be discovered with a 20-year breast cancer screening schedule of every two years. 77 women out of 1,000 who undergo a mammography every two years for 20 years will develop breast cancer. 21 of them will receive cancer diagnoses while having normal mammogram results.

This can happen if: every person with breast cancer will survive; The cancer was not detected on the mammogram; The cancer had not yet been established at the point of the mammography. It is predicted that 13 women out of 1,000 who receive mammograms every two years for 20 years will pass away from breast cancer. A mammography is an X-ray as well. Radiations are released during X-ray exams like with all others.

COVID-19 Impact Analysis

The COVID-19 epidemic and the worldwide lockdown have had an effect on the financial health of businesses in all industries. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the duration of the COVID-19 health emergency that include general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global breast imaging market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global breast imaging market growth over the forecast period.

Segment Analysis

The global breast imaging market is segmented based on modalities, application, end-user and region.

Breast Cancer From the Application Segment Accounts for 62.8% of the Market Share Owing to the High Incidence

Cancer is a condition when the body's cells proliferate out of control. Aside from skin cancer, breast cancer is the most common type of cancer in women in the US. Breast cancer remains the second-leading cause of cancer deaths amongst all women and is particularly prevalent among Hispanic women, despite a decline in the number of fatalities from the disease over time.

In the US, around 2,400 men and 264,000 women receive a breast cancer diagnosis each year. Each year, breast cancer claims the lives of 42,000 women and 500 men in the United States. Black women suffer from a higher breast cancer death rate than White women. Breast ultrasonography and mammography along with MRI can be helpful diagnostic tools.

According to recent studies, MRI can find some tiny breast tumors that mammography occasionally misses. Additionally, it can aid in the early detection of breast cancer in younger women with dense breast tissue and in those who have breast implants. Mammography might not be as useful in these circumstances. MRIs don't use radiation, so they can be used to screen people under 40 and increase the number of tests for people who are at elevated risk for breast cancer each year.

Geographical Analysis

North America Accounted for Approximately 39.6% of the Market Share Owing to the Strong Presence of Major Players and the Advancements in Breast Imaging

Manufacturers have chances to expand their operations in this region because of the rising demand for Breast Imaging for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of Breast Imaging, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for research and development of novel products.

The market will grow as new technology for research and development emerge. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. People are becoming more aware of novel products and therapies, leading to the expansion of the market in this region. These factors are responsible for the dominance of North America.

Competitive Landscape

The major global players in the breast imaging market include: GE Healthcare, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips NV, Hologic, Inc., Canon Medical Systems Corporation, Inc., General Medical Merate S.p.A., Konica Minolta Healthcare Americas, Inc., Metaltronica S.p.A and Planmed OY among others.

Why Purchase the Report?

  • To visualize the global breast imaging market segmentation based on modalities, applications, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of breast imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global breast imaging market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers / Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Modalities
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Technological Advancements and Novel Product Launches
      • 4.1.1.2. The Rising Incidence of Breast Cancer
    • 4.1.2. Restraints
      • 4.1.2.1. Limitations Associated with Equipment
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launches
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Modalities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 7.1.2. Market Attractiveness Index, By Modalities
  • 7.2. X-Ray Source *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Mammography
    • 7.2.4. Digital Breast Tomosynthesis
    • 7.2.5. Contrast-Enhanced Digital Mammography
  • 7.3. Ultrasound
    • 7.3.1. Sonography
    • 7.3.2. Contrast-Enhanced Ultrasound
    • 7.3.3. Three-Dimensional Ultrasound
    • 7.3.4. Color/Power Doppler
    • 7.3.5. Tissue Elasticity Imaging
  • 7.4. Magnetic Field
    • 7.4.1. Magnetic Resonance Imaging
    • 7.4.2. Magnetic Resonance Spectroscopy
    • 7.4.3. Diffusion-Weighted Imaging
  • 7.5. Gamma Radiation
    • 7.5.1. Positron Emission Tomography
    • 7.5.2. Single-Photon Emission Computed Tomography
  • 7.6. Non-Ionizing Radiation
    • 7.6.1. Optical Imaging
    • 7.6.2. Breast Microwave Imaging

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Breast Cancer *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Breast Disease
  • 8.4. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Imaging Centres
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modalities
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare GmbH
  • 12.3. FUJIFILM Corporation
  • 12.4. Koninklijke Philips NV
  • 12.5. Hologic, Inc.
  • 12.6. Canon Medical Systems Corporation
  • 12.7. General Medical Merate S.p.A.
  • 12.8. Konica Minolta Healthcare Americas, Inc.
  • 12.9. Metaltronica S.p.A
  • 12.10. Planmed OY

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us